Molecular basis of cancer diathesis
癌症素质的分子基础
基本信息
- 批准号:14032201
- 负责人:
- 金额:$ 60.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To develop new strategies to suppress carcinogenesis and to control cancer progression, it is critical to understand the fundamental roles and regulatory features of proto-oncogene and anti-oncogene products at the molecular level. In this study, we extensively analyzed the normal functions and regulation of the src family of proto-oncogene products (SFK) in order to understand the role played by SFK in cancer progression, and particularly in the acquisition of metastatic activity.1. Studies of epithelial cancer cells and mutant mice that lack Csk, a negative regulator of SFK, revealed that SFK plays critical roles in cell migration and in the regulation of the epithelial-like cell to mesencymal-like cell transition (EMT). It was also found that SFK is involved in the cell-cell adhesion required for the maintenance of cell polarity and for the regulation of cell proliferation through the control of cytoskeletal organization. Cortactin, an actin binding protein, and its associated molec … More ules were identified as potential targets of SFK in the epithelial-like cell to mesencymal-like cell transition. Furthermore, Csk acted as the critical regulator of these phenomena, suggesting that Csk could be used as a potential therapeutic target to control cancer progression and/or metastasis. 2. In the lipid raft fraction that provides a platform for SFK signaling, we identified a novel membrane phosphoprotein Cbp (Csk binding protein) as an initial target of SFK, and showed that it serves as a membrane scaffold protein for Csk. 3. To analyze the fundamental roles of SFK in animals, we identified SFK and Csk orthologues in C. elegans. Analysis of mutant worms revealed that SRC-1, an orthologue of Src, plays an essential role in controlling the migration of specific cell types during organogenesis. The Rac signaling pathway was identified as a downstream target of SRC-1. 4. Based on the structural information provided by the crystal structure of Csk, we proposed a molecular basis for SFK regulation by Csk. Less
为了制定抑制癌变并控制癌症进展的新策略,了解原始癌基因和抗癌基因在分子水平上的基本作用和调节特征至关重要。在这项研究中,我们广泛分析了SRC家族的正常功能和调节原癌基因产品(SFK),以了解SFK在癌症进展中所起的作用,尤其是在转移性活动中所起的作用。1。对SFK的负调节剂缺乏CSK的上皮癌细胞和突变小鼠的研究表明,SFK在细胞迁移以及对上皮样细胞对介体样细胞转变(EMT)的调节中起关键作用。还发现SFK参与了维持细胞极性所需的细胞 - 细胞粘附,并通过控制细胞骨架组织来调节细胞增殖。肌动蛋白结合蛋白及其相关的分子……更多的ULE被鉴定为上皮样细胞中SFK的潜在靶标的肌动蛋白的结合蛋白。此外,CSK充当这些现象的关键调节剂,这表明CSK可以用作控制癌症进展和/或转移的潜在治疗靶标。 2。在为SFK信号提供平台的脂质筏部分中,我们确定了一种新型的膜磷酸蛋白CBP(CSK结合蛋白)为SFK的初始靶标,并表明它是CSK的膜支架蛋白。 3。为了分析SFK在动物中的基本作用,我们确定了秀丽隐杆线虫中的SFK和CSK直系同源物。对突变蠕虫的分析表明,SRC-1(SRC的直系同源物)在控制器官发生过程中特定细胞类型的迁移中起着至关重要的作用。 RAC信号通路被确定为SRC-1的下游目标。 4。基于CSK晶体结构提供的结构信息,我们提出了CSK调节SFK调控的分子基础。较少的
项目成果
期刊论文数量(67)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shimizu, K.: "SCOP, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway"J. Biol. Chem.. (in press). (2003)
Shimizu, K.:“SCOP 是膜筏中 K-Ras 的一种新型结合伴侣,对 MAPK 通路具有负调节作用”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Activation of Cdc42 by trans interactions of the cell adhesion molecules nectins through c-Src and Cdc42-GEF FRG.
- DOI:10.1083/jcb.200401093
- 发表时间:2004-08-02
- 期刊:
- 影响因子:0
- 作者:Fukuhara T;Shimizu K;Kawakatsu T;Fukuyama T;Minami Y;Honda T;Hoshino T;Yamada T;Ogita H;Okada M;Takai Y
- 通讯作者:Takai Y
Mechanism of Csk-mediated down regulation of Src family tyrosine kinases in EGF signaling.
EGF 信号传导中 Csk 介导的 Src 家族酪氨酸激酶下调机制。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Mimuro;M.;H.Kikuchi;Matsuoka H
- 通讯作者:Matsuoka H
Csk regulates integrin-mediated signals : involvement of differential activation of ERK and Akt.
Csk 调节整合素介导的信号:参与 ERK 和 Akt 的差异激活。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Gu;J.
- 通讯作者:J.
Kono, H.: "Spatial raft coalescence represents an initial step in Fc gamma R signaling"J. Immunol.. 169. 193-203 (2002)
Kono, H.:“空间筏合并代表 Fc gamma R 信号传导的第一步”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKADA Masato其他文献
Likelihood Identification of High-Beta Disruption in JT-60U
JT-60U 中高 Beta 破坏的可能性识别
- DOI:
10.1585/pfr.16.1402073 - 发表时间:
2021 - 期刊:
- 影响因子:0.8
- 作者:
YOKOYAMA Tatsuya;YAMADA Hiroshi;ISAYAMA Akihiko;HIWATARI Ryoji;IDE Shunsuke;MATSUNAGA Go;MIYOSHI Yuya;OYAMA Naoyuki;IMAGAWA Naoto;IGARASHI Yasuhiko;OKADA Masato;OGAWA Yuichi - 通讯作者:
OGAWA Yuichi
OKADA Masato的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKADA Masato', 18)}}的其他基金
Bayesian theory for spectral deconvolution and its expansion
谱反卷积的贝叶斯理论及其扩展
- 批准号:
24654118 - 财政年份:2012
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Probabilistic model for non-photorealistic image based on view point and its application to computer graphics
基于视点的非真实感图像概率模型及其在计算机图形学中的应用
- 批准号:
22650041 - 财政年份:2010
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Regulation of tumor growth via intracellular membrane compartments
通过细胞内膜区室调节肿瘤生长
- 批准号:
22240088 - 财政年份:2010
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Visualization of a picture for information science and computer science
信息科学和计算机科学图片的可视化
- 批准号:
20240020 - 财政年份:2008
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Roles of tyrosine kinases during evolution of multicellular animals
酪氨酸激酶在多细胞动物进化过程中的作用
- 批准号:
19370053 - 财政年份:2007
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Estimations of neural networks by fluctuations of neuron spikes
通过神经元尖峰的波动来估计神经网络
- 批准号:
18079003 - 财政年份:2006
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
The Molecular basis of tyrosine kinase signaling
酪氨酸激酶信号传导的分子基础
- 批准号:
17012015 - 财政年份:2005
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Role of tyrosine kinase in the evolution of multicellular animals
酪氨酸激酶在多细胞动物进化中的作用
- 批准号:
17370048 - 财政年份:2005
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Discrete and continuous compressed information representation using phase transition phenomena
使用相变现象的离散和连续压缩信息表示
- 批准号:
16500093 - 财政年份:2004
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of tyrosine kinase in the evolution of multicellular animals
酪氨酸激酶在多细胞动物进化中的作用
- 批准号:
15370056 - 财政年份:2003
- 资助金额:
$ 60.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
可代谢调控弱碱性钠盐纳米材料的控制合成及其在增强癌症免疫治疗中的应用
- 批准号:52372273
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
纤毛发生相关激酶-1在癌症进展和耐药中的作用与机制研究
- 批准号:82373161
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
药效关联的癌症单细胞亚群识别与精准联合医疗研究
- 批准号:32370702
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向癌症驱动因子识别及其调控作用预测的因果推断方法研究
- 批准号:62372210
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于癌症Hallmark的高性能可解释ICI药物响应预测模型研究
- 批准号:62372134
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Target the Dusp1 in Jak2 dependent myeloproliferative neoplasm (MPN) for curative treatment
针对 Jak2 依赖性骨髓增生性肿瘤 (MPN) 中的 Dusp1 进行治愈性治疗
- 批准号:
10655109 - 财政年份:2023
- 资助金额:
$ 60.22万 - 项目类别:
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
新辅助来那替尼治疗 I-III 期 HER2 突变小叶乳腺癌
- 批准号:
10660734 - 财政年份:2023
- 资助金额:
$ 60.22万 - 项目类别:
Characterizing treatment responses for common lung cancer (LC) subtypes in Latinos and Asians
描述拉丁裔和亚洲人常见肺癌 (LC) 亚型的治疗反应
- 批准号:
10733396 - 财政年份:2023
- 资助金额:
$ 60.22万 - 项目类别:
Dissecting the role and mechanism of EML4-ALK condensates in oncogenic signaling and tumor growth
剖析 EML4-ALK 缩合物在致癌信号和肿瘤生长中的作用和机制
- 批准号:
10634392 - 财政年份:2023
- 资助金额:
$ 60.22万 - 项目类别:
Unmet needs for specific subsets of EGFR mutated lung cancer
EGFR 突变肺癌特定亚型的需求未得到满足
- 批准号:
10441928 - 财政年份:2023
- 资助金额:
$ 60.22万 - 项目类别: